These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 19293637)
1. Reactive oxygen species regulate the generation of urokinase plasminogen activator in human hepatoma cells via MAPK pathways after treatment with hepatocyte growth factor. Lee KH; Kim JR Exp Mol Med; 2009 Mar; 41(3):180-8. PubMed ID: 19293637 [TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species regulate urokinase plasminogen activator expression and cell invasion via mitogen-activated protein kinase pathways after treatment with hepatocyte growth factor in stomach cancer cells. Lee KH; Kim SW; Kim JR J Exp Clin Cancer Res; 2009 Jun; 28(1):73. PubMed ID: 19497102 [TBL] [Abstract][Full Text] [Related]
3. Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis. Lee KH; Hyun MS; Kim JR Clin Exp Metastasis; 2003; 20(6):499-505. PubMed ID: 14598883 [TBL] [Abstract][Full Text] [Related]
4. Regulation of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MEK/ERK activation in human stomach cancer cell lines. Lee KH; Choi EY; Kim MK; Hyun MS; Jang BI; Kim TN; Kim SW; Song SK; Kim JH; Kim JR Exp Mol Med; 2006 Feb; 38(1):27-35. PubMed ID: 16520550 [TBL] [Abstract][Full Text] [Related]
5. Cellular mechanisms of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MAPK signaling in hepatocellular carcinoma. Lee KH; Choi EY; Hyun MS; Eun JR; Jang BI; Kim TN; Lee HJ; Lee DS; Yun SS; Kim HJ; Kim JH; Kim JR Tumori; 2008; 94(4):523-30. PubMed ID: 18822689 [TBL] [Abstract][Full Text] [Related]
6. Nicotine stimulates urokinase-type plasminogen activator receptor expression and cell invasiveness through mitogen-activated protein kinase and reactive oxygen species signaling in ECV304 endothelial cells. Khoi PN; Park JS; Kim NH; Jung YD Toxicol Appl Pharmacol; 2012 Mar; 259(2):248-56. PubMed ID: 22261521 [TBL] [Abstract][Full Text] [Related]
7. Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target. Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Lee HJ; Eun JY; Kim HG; Yoon SS; Lee DS; Kim JH; Kim JR Clin Exp Metastasis; 2008; 25(1):89-96. PubMed ID: 17992475 [TBL] [Abstract][Full Text] [Related]
8. IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment. Lee KH; Choi EY; Koh SA; Kim MK; Jang BI; Kim SW; Kim JR Oncol Rep; 2014 May; 31(5):2123-30. PubMed ID: 24626561 [TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species stimulated human hepatoma cell proliferation via cross-talk between PI3-K/PKB and JNK signaling pathways. Liu SL; Lin X; Shi DY; Cheng J; Wu CQ; Zhang YD Arch Biochem Biophys; 2002 Oct; 406(2):173-82. PubMed ID: 12361705 [TBL] [Abstract][Full Text] [Related]
14. Effects of hepatocyte growth factor on urokinase-type plasminogen activator (uPA) and uPA receptor in DU145 prostate cancer cells. Nishimura K; Matsumiya K; Miura H; Tsujimura A; Nonomura N; Matsumoto K; Nakamura T; Okuyama A Int J Androl; 2003 Jun; 26(3):175-9. PubMed ID: 12755996 [TBL] [Abstract][Full Text] [Related]
15. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor. Nicholl SM; Roztocil E; Davies MG J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933 [TBL] [Abstract][Full Text] [Related]
16. Redox regulation of reactive oxygen species-induced p38 MAP kinase activation and barrier dysfunction in lung microvascular endothelial cells. Usatyuk PV; Vepa S; Watkins T; He D; Parinandi NL; Natarajan V Antioxid Redox Signal; 2003 Dec; 5(6):723-30. PubMed ID: 14588145 [TBL] [Abstract][Full Text] [Related]
17. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity. Huang S; New L; Pan Z; Han J; Nemerow GR J Biol Chem; 2000 Apr; 275(16):12266-72. PubMed ID: 10766865 [TBL] [Abstract][Full Text] [Related]
18. Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor. Bauer TW; Fan F; Liu W; Johnson M; Parikh NU; Parry GC; Callahan J; Mazar AP; Gallick GE; Ellis LM Ann Surg; 2005 May; 241(5):748-56; discussion 756-8. PubMed ID: 15849510 [TBL] [Abstract][Full Text] [Related]
19. Regulation by p38 mitogen-activated protein kinase of adenylate- and uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent in vitro cell invasion. Montero L; Nagamine Y Cancer Res; 1999 Oct; 59(20):5286-93. PubMed ID: 10537311 [TBL] [Abstract][Full Text] [Related]
20. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]